Wanbangde Pharmaceutical Holding Group Co Ltd (002082) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Based on the latest financial reports, Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.04 Million ≈ $-151.51K USD) by net assets (CN¥2.77 Billion ≈ $404.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002082 net asset quality score to measure how much of total assets are equity-financed.

Wanbangde Pharmaceutical Holding Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Wanbangde Pharmaceutical Holding Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002082 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Wanbangde Pharmaceutical Holding Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wanbangde Pharmaceutical Holding Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Center Laboratories TWO:4123	0.002x
Shanghai Aladdin Biochemical Technology Co. Ltd. A SHG:688179	N/A
Country Garden Holdings Company Limited F:DZJ	0.038x
MONGOLIAN MINING CRP.REGS F:29X2	N/A
Zhejiang Baoxiniao Garment Co Ltd SHE:002154	0.001x
Gansu Yasheng Industrial Group Co Ltd SHG:600108	0.005x
GrocerIQ, Inc NYSE:WPFHD	N/A
Cullinan Oncology LLC NASDAQ:CGEM	-0.126x

Annual Cash Flow Conversion Efficiency for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Wanbangde Pharmaceutical Holding Group C.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.61 Billion ≈ $381.57 Million	CN¥603.98 Million ≈ $88.38 Million	0.232x	+431.07%
2024-12-31	CN¥2.76 Billion ≈ $403.35 Million	CN¥120.22 Million ≈ $17.59 Million	0.044x	+265.13%
2023-12-31	CN¥2.76 Billion ≈ $403.72 Million	CN¥-72.87 Million ≈ $-10.66 Million	-0.026x	+68.93%
2022-12-31	CN¥2.82 Billion ≈ $412.52 Million	CN¥-239.65 Million ≈ $-35.07 Million	-0.085x	-1156.46%
2021-12-31	CN¥2.74 Billion ≈ $401.63 Million	CN¥22.09 Million ≈ $3.23 Million	0.008x	-84.77%
2020-12-31	CN¥2.86 Billion ≈ $418.23 Million	CN¥151.01 Million ≈ $22.10 Million	0.053x	+140.62%
2019-12-31	CN¥1.91 Billion ≈ $279.76 Million	CN¥-248.69 Million ≈ $-36.39 Million	-0.130x	-265.60%
2018-12-31	CN¥1.72 Billion ≈ $252.22 Million	CN¥135.40 Million ≈ $19.81 Million	0.079x	+815.48%
2017-12-31	CN¥1.60 Billion ≈ $234.64 Million	CN¥-17.60 Million ≈ $-2.58 Million	-0.011x	-104.93%
2016-12-31	CN¥1.40 Billion ≈ $204.36 Million	CN¥310.71 Million ≈ $45.47 Million	0.222x	+1687.76%
2015-12-31	CN¥1.35 Billion ≈ $197.11 Million	CN¥16.76 Million ≈ $2.45 Million	0.012x	-88.50%
2014-12-31	CN¥1.30 Billion ≈ $189.69 Million	CN¥140.31 Million ≈ $20.53 Million	0.108x	-45.14%
2013-12-31	CN¥1.19 Billion ≈ $173.83 Million	CN¥234.35 Million ≈ $34.29 Million	0.197x	+6.79%
2012-12-31	CN¥1.10 Billion ≈ $160.59 Million	CN¥202.73 Million ≈ $29.67 Million	0.185x	+13651.98%
2011-12-31	CN¥1.05 Billion ≈ $154.24 Million	CN¥-1.44 Million ≈ $-210.26K	-0.001x	-100.79%
2010-12-31	CN¥936.13 Million ≈ $136.98 Million	CN¥162.26 Million ≈ $23.74 Million	0.173x	+106.47%
2009-12-31	CN¥811.59 Million ≈ $118.76 Million	CN¥68.13 Million ≈ $9.97 Million	0.084x	-76.37%
2008-12-31	CN¥712.31 Million ≈ $104.23 Million	CN¥253.06 Million ≈ $37.03 Million	0.355x	+1084.23%
2007-12-31	CN¥415.12 Million ≈ $60.74 Million	CN¥12.45 Million ≈ $1.82 Million	0.030x	+206.57%
2006-12-31	CN¥357.72 Million ≈ $52.35 Million	CN¥3.50 Million ≈ $512.24K	0.010x	-86.67%
2005-12-31	CN¥152.88 Million ≈ $22.37 Million	CN¥11.23 Million ≈ $1.64 Million	0.073x	-69.41%
2004-12-31	CN¥136.17 Million ≈ $19.93 Million	CN¥32.69 Million ≈ $4.78 Million	0.240x	-36.09%
2003-12-31	CN¥98.53 Million ≈ $14.42 Million	CN¥37.01 Million ≈ $5.42 Million	0.376x	--

About Wanbangde Pharmaceutical Holding Group Co Ltd

SHE:002082 China Drug Manufacturers - Specialty & Generic

Market Cap

$895.09 Million

CN¥6.12 Billion CNY

Market Cap Rank

#9278 Global

#2294 in China

Share Price

CN¥10.00

Change (1 day)

+1.94%

52-Week Range

CN¥7.19 - CN¥36.24

All Time High

CN¥36.24